Jazz Pharmaceuticals PLC $163.64

up +0.41


19/9/2014 04:00 PM  |  NASDAQ : JAZZ  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get JAZZ Trend Analysis - it has outperformed the S&P 500 by 66%

Partner Headlines

  1. Five Leading International Stocks Near Buy Points

    IBD
  2. Valeant, Allergan Settle Suit, Allow Shareholder Vote

    IBD
  3. IBD 50 Names Hold Gains, But Actionable Charts Scarce

    IBD
  4. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD
  5. IBD 50 Names Hold Gains, But Actionable Charts Scarce

    IBD
  6. Stocks Reverse Higher, But Some Retailers Sell Off

    IBD
  7. Jazz Pharmaceuticals Up On Allergan, Inc. Rumor

    Benzinga
  8. Stocks Rise, Turn Positive Going Into Final Hour

    IBD
  9. Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead

    IBD
  10. Baidu, AerCap And Jazz Among Basing Top World Stocks

    IBD
  11. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD
  12. Major Indexes Turn Mixed; Jazz Pharmaceuticals Turns Up

    IBD
  13. Salix Soars On Allergan Buzz

    IBD
  14. Indexes Rally On Strong Housing Data, Retail Reports

    IBD
  15. Stocks Add To Gains; Salix Surges On Potential Bid

    IBD
  16. JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And ...

    Benzinga
  17. Jazz, Celgene Lead Top 4 Drugmaker Profit Margins

    IBD
  18. Jazz Pharmaceuticals Is Taking Two Routes To Growth

    IBD
  19. Stocks Backslide Into Losses; Jazz Pharma, Kinder Morgan Rise

    IBD
  20. Nasdaq Leads Indexes As Solar, Biotechs Outperform

    IBD
  21. Afternoon Selling Holds Stocks In Check

    IBD
  22. Stocks Muted; Keurig Green Mountain Down After Hours

    IBD
  23. Indexes Close Flat After Seesaw Session

    IBD
  24. Jazz Pharma Jumps After Q2 Earnings Rebound

    IBD
  25. Stocks Turn Tightly Mixed; Walgreen, Nu Skin Collapse

    IBD
  26. Morning Market Movers

    Benzinga
  27. Jazz Pharmaceuticals Spikes In #PreMarket On Q2 Beat; Boosts Revenue Outlook

    Benzinga
  28. Benzinga's Top #PreMarket Gainers

    Benzinga
  29. Drugmaker Q2 Profits Robust

    IBD
  30. 4 Top-Rated Drugmakers Beat Q2 Earnings Estimates

    IBD
  31. Ukraine Jitters Send Stocks Lower In Afternoon Trade

    IBD
  32. Stocks Fall In Fast Trade; First Solar Down On Earnings

    IBD
  33. Actavis Guidance Disappoints; Akorn Beats And Raises

    IBD
  34. Prescription Drugmakers Slide Down Industry Rankings

    IBD
  35. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD
  36. Cup-With-Handle Pattern Can Yield Powerful Breakouts

    IBD
  37. Benzinga's Top Initiations

    Benzinga
  38. Buckingham Research Initiates Jazz Pharmaceuticals With Buy

    Benzinga
  39. Irish Stocks Come To Prominence As Taxes Stay Low

    IBD
  40. Market Slides On European Bank Worries; Gold Stocks Rise

    IBD
  41. Salix Pharma Stock Falls Despite Tax-Inversion Deal

    IBD
  42. Jazz, Novo Among Medicals Showing Healthy Action

    IBD
  43. Stocks Add To Losses; TAL Education Bucks Weakness

    IBD
  44. Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week

    IBD
  45. Jazz buys out new drug rights

    IBD
  46. Stocks End Mixed In Light Trade As Jobs Report Looms

    IBD
  47. Stocks Nearly Flat In Quiet Trading With 1 Hour To Go

    IBD
  48. Jazz Pharma Buys Out Rights To Newly Acquired Drug

    IBD
  49. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD
  50. Weekly CFO Sells Highlight: Google Inc, Jazz Pharmaceuticals PLC, Jack ...

    GuruFocus
Trading Center